Fundraising FoxAglaia Oncology Funds
5 known investors
Find your way into Aglaia Oncology Funds
Sign up to see every warm intro you have to Aglaia Oncology Funds
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Aglaia Oncology Funds team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Aglaia is an investment firm specializing in early-stage oncology drug development companies, selecting and maturing breakthrough inventions with potential to transform cancer treatment. The firm has invested in 12 early-stage companies since 2004, six of which it founded, and has been involved in developing over 100 oncology products.
Investors · 5
Aurora SciencereportedMilano
How we know: funding news · Not right? Tell us
Cathay VenturereportedTaipei
How we know: funding news · Not right? Tell us
KorysreportedHalle · $5.4M
How we know: funding news · Not right? Tell us
Oost NLreportedApeldoorn · $108K – $5.4M
How we know: funding news · Not right? Tell us
In the news
Frequently asked questions
- What does Aglaia Oncology Funds do?
- Aglaia is an investment firm specializing in early-stage oncology drug development companies, selecting and maturing breakthrough inventions with potential to transform cancer treatment. The firm has invested in 12 early-stage companies since 2004, six of which it founded, and has been involved in developing over 100 oncology products.
- Who are Aglaia Oncology Funds's investors?
- Aglaia Oncology Funds's investors include BOM, Aurora Science, Cathay Venture, Korys, Oost NL.